Mini Samples ELISA Kit for Tumor Necrosis Factor Receptor 1 (TNFR1)

CD120A; P55; TNFRSF1A; TBP1; FPF; TNF-R; TNF-R-I; TNF-R55; TNFAR; TNFR55; TNFR60; P55-R; P60; Tumor necrosis factor receptor 1; Tumor necrosis factor-binding protein 1

Specificity

This assay has high sensitivity and excellent specificity for detection of Mini Samples Tumor Necrosis Factor Receptor 1 (TNFR1).
No significant cross-reactivity or interference between Mini Samples Tumor Necrosis Factor Receptor 1 (TNFR1) and analogues was observed.

Recovery

Matrices listed below were spiked with certain level of recombinant Mini Samples Tumor Necrosis Factor Receptor 1 (TNFR1) and the recovery rates were calculated by comparing the measured value to the expected amount of Mini Samples Tumor Necrosis Factor Receptor 1 (TNFR1) in samples.

Matrix Recovery range (%) Average(%)
serum(n=5) 93-104 99
EDTA plasma(n=5) 95-103 99
heparin plasma(n=5) 86-101 92

Precision

Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Mini Samples Tumor Necrosis Factor Receptor 1 (TNFR1) were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level Mini Samples Tumor Necrosis Factor Receptor 1 (TNFR1) were tested on 3 different plates, 8 replicates in each plate.
CV(%) = SD/meanX100
Intra-Assay: CV<10%
Inter-Assay: CV<12%

Linearity

The linearity of the kit was assayed by testing samples spiked with appropriate concentration of Mini Samples Tumor Necrosis Factor Receptor 1 (TNFR1) and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.

Sample 1:2 1:4 1:8 1:16
serum(n=5) 83-104% 99-105% 89-97% 80-104%
EDTA plasma(n=5) 93-101% 91-104% 85-92% 79-96%
heparin plasma(n=5) 91-102% 93-105% 78-105% 81-97%

Stability

The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.

Reagents and materials provided

Reagents Quantity Reagents Quantity
Pre-coated, ready to use 96-well strip plate 1 Plate sealer for 96 wells 4
Standard 2 Standard Diluent 1×20mL
Detection Reagent A 1×60µL Assay Diluent A 1×6mL
Detection Reagent B 1×60µL Assay Diluent B 1×6mL
TMB Substrate 1×4.5mL Stop Solution 1×3mL
Wash Buffer (30 × concentrate) 1×10mL Instruction manual 1

Assay procedure summary

1. Prepare all reagents, samples and standards;
2. Add 25µL standard or sample to each well. Incubate 1 hour at 37°C;
3. Aspirate and add 25µL prepared Detection Reagent A. Incubate 1 hour at 37°C;
4. Aspirate and wash 3 times;
5. Add 25µL prepared Detection Reagent B. Incubate 30 minutes at 37°C;
6. Aspirate and wash 5 times;
7. Add 25µL Substrate Solution. Incubate 10-20 minutes at 37°C;
8. Add 20µL Stop Solution. Read at 450nm immediately.

GIVEAWAYS

INCREMENT SERVICES

Magazine Citations
PLoS ONE A Combinatorial Relative Mass Value Evaluation of Endogenous Bioactive Proteins in Three-Dimensional Cultured Nucleus Pulposus Cells of Herniated Intervertebral Discs: Identification of Potential Target Proteins for Gene Therapeutic Approaches Plosone: Source
Mediators of Inflammation High Glucose Level Disturbs the Resveratrol-Evoked Curtailment of CX3CL1/CX3CR1 Signaling in Human Placental Circulation pubmed:28655972
Annals of Neurology  High complement levels in astrocyte‐derived exosomes of Alzheimer disease Pubmed:29406582
International Journal of Immunopathology and Pharmacology VEGF-R2 and TNF-R1 expression and cytokine production by samples of mammary adenocarcinomas and correlations with histopathological parameters of these … Pubmed:29985074
Cell Death & Disease Inhibition of transmembrane TNF-α shedding by a specific antibody protects against septic shock Pubmed: 31383857
Journal of Cardiovascular Translational Research XPO1 Gene Therapy Attenuates Cardiac Dysfunction in Rats with Chronic Induced Myocardial Infarction Pubmed: 31768947
Frontiers in Pharmacology M10, a Myricetin-3-ObD-Lactose Sodium Salt, Prevents Ulcerative Colitis Through Inhibiting Necroptosis in Mice Pubmed: 33041798
Catalog No. Related products for research use of Homo sapiens (Human) Organism species Applications (RESEARCH USE ONLY!)
APB499Hu02 Active Tumor Necrosis Factor Receptor 1 (TNFR1) Cell culture; Activity Assays.
RPB499Hu03 Recombinant Tumor Necrosis Factor Receptor 1 (TNFR1) Positive Control; Immunogen; SDS-PAGE; WB.
RPB499Hu01 Recombinant Tumor Necrosis Factor Receptor 1 (TNFR1) Positive Control; Immunogen; SDS-PAGE; WB.
APB499Hu01 Active Tumor Necrosis Factor Receptor 1 (TNFR1) Cell culture; Activity Assays.
RPB499Hu02 Recombinant Tumor Necrosis Factor Receptor 1 (TNFR1) Positive Control; Immunogen; SDS-PAGE; WB.
PAB499Hu01 Polyclonal Antibody to Tumor Necrosis Factor Receptor 1 (TNFR1) WB; IHC; ICC; IP.
PAB499Hu02 Polyclonal Antibody to Tumor Necrosis Factor Receptor 1 (TNFR1) WB,IHC
MAB499Hu21 Monoclonal Antibody to Tumor Necrosis Factor Receptor 1 (TNFR1) WB; IHC; ICC; IP.
MEB499Hu Mini Samples ELISA Kit for Tumor Necrosis Factor Receptor 1 (TNFR1) Enzyme-linked immunosorbent assay for Antigen Detection.
SEB499Hu ELISA Kit for Tumor Necrosis Factor Receptor 1 (TNFR1) Enzyme-linked immunosorbent assay for Antigen Detection.
LMB499Hu Multiplex Assay Kit for Tumor Necrosis Factor Receptor 1 (TNFR1) ,etc. by FLIA (Flow Luminescence Immunoassay) FLIA Kit for Antigen Detection.